[Dyslipidemia and hypertension - what to worry about more?]

Vnitrni Lekarstvi
|May 24, 2018
PubMed

Insights

Nearly half of patients with arterial hypertension also have dyslipidemia. Combined treatment for both conditions, especially with fixed drug combinations, significantly reduces cardiovascular events and mortality.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Dyslipidemia affects approximately 50% of patients with arterial hypertension.
  • Elevated blood pressure and cholesterol levels are directly proportional to cardiovascular event risk.

Purpose of the Study:

  • To highlight the significant impact of dyslipidemia on cardiovascular risk in hypertensive patients.
  • To emphasize the benefits of combined treatment for hypertension and dyslipidemia.
  • To explore the role of fixed drug combinations in improving treatment adherence and efficacy.

Main Methods:

  • Review of existing literature on the co-occurrence of arterial hypertension and dyslipidemia.
  • Analysis of cardiovascular event rates in patients treated for one or both conditions.
  • Evaluation of the impact of fixed-dose drug combinations on patient adherence and outcomes.

Main Results:

  • Treatment of dyslipidemia shows a greater reduction in cardiovascular mortality than hypertension treatment alone.
  • Concurrent treatment of both conditions yields significantly better outcomes than monotherapy.
  • Fixed drug combinations enhance adherence and improve the efficacy of combined therapy.

Conclusions:

  • Managing dyslipidemia is crucial in patients with arterial hypertension.
  • Combined pharmacotherapy for hypertension and dyslipidemia is superior to monotherapy.
  • Fixed drug combinations represent an effective strategy to improve adherence and reduce cardiovascular events.

Related Concept Videos

Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
940
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
990
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
472
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.5K
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
664
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
602